Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 18 03 2019
accepted: 08 08 2019
revised: 13 07 2019
pubmed: 31 8 2019
medline: 5 6 2020
entrez: 31 8 2019
Statut: ppublish

Résumé

To present a deep learning-based approach for semi-automatic prostate cancer classification based on multi-parametric magnetic resonance (MR) imaging using a 3D convolutional neural network (CNN). Two hundred patients with a total of 318 lesions for which histological correlation was available were analyzed. A novel CNN was designed, trained, and validated using different combinations of distinct MRI sequences as input (e.g., T2-weighted, apparent diffusion coefficient (ADC), diffusion-weighted images, and K-trans) and the effect of different sequences on the network's performance was tested and discussed. The particular choice of modeling approach was justified by testing all relevant data combinations. The model was trained and validated using eightfold cross-validation. In terms of detection of significant prostate cancer defined by biopsy results as the reference standard, the 3D CNN achieved an area under the curve (AUC) of the receiver operating characteristics ranging from 0.89 (88.6% and 90.0% for sensitivity and specificity respectively) to 0.91 (81.2% and 90.5% for sensitivity and specificity respectively) with an average AUC of 0.897 for the ADC, DWI, and K-trans input combination. The other combinations scored less in terms of overall performance and average AUC, where the difference in performance was significant with a p value of 0.02 when using T2w and K-trans; and 0.00025 when using T2w, ADC, and DWI. Prostate cancer classification performance is thus comparable to that reported for experienced radiologists using the prostate imaging reporting and data system (PI-RADS). Lesion size and largest diameter had no effect on the network's performance. The diagnostic performance of the 3D CNN in detecting clinically significant prostate cancer is characterized by a good AUC and sensitivity and high specificity. • Prostate cancer classification using a deep learning model is feasible and it allows direct processing of MR sequences without prior lesion segmentation. • Prostate cancer classification performance as measured by AUC is comparable to that of an experienced radiologist. • Perfusion MR images (K-trans), followed by DWI and ADC, have the highest effect on the overall performance; whereas T2w images show hardly any improvement.

Identifiants

pubmed: 31468158
doi: 10.1007/s00330-019-06417-z
pii: 10.1007/s00330-019-06417-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1243-1253

Subventions

Organisme : German Research Foundation
ID : GRK2260

Références

Phys Med Biol. 2017 Jul 24;62(16):6497-6514
pubmed: 28582269
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Eur Radiol. 2017 Jun;27(6):2348-2358
pubmed: 27620864
Med Image Anal. 2013 Feb;17(2):219-35
pubmed: 23294985
Ann Intern Med. 2011 Dec 6;155(11):762-71
pubmed: 21984740
Proc SPIE Int Soc Opt Eng. 2017 Feb 11;10134:
pubmed: 28615793
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6265-73
pubmed: 26578786
Comput Biol Med. 2015 May;60:8-31
pubmed: 25747341
Eur Urol. 2015 Jul;68(1):8-19
pubmed: 25454618
Radiology. 2013 Jun;267(3):787-96
pubmed: 23392430
IEEE Trans Med Imaging. 2016 May;35(5):1285-98
pubmed: 26886976
Med Image Anal. 2017 Dec;42:212-227
pubmed: 28850876
IEEE Trans Med Imaging. 2014 May;33(5):1083-92
pubmed: 24770913
Nat Rev Clin Oncol. 2014 Jun;11(6):346-53
pubmed: 24840072
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Eur J Radiol. 2016 Apr;85(4):726-31
pubmed: 26971415
N Engl J Med. 2009 Mar 26;360(13):1320-8
pubmed: 19297566
IEEE Trans Med Imaging. 2016 May;35(5):1299-1312
pubmed: 26978662

Auteurs

Nader Aldoj (N)

Department of Radiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. nader.aldoj@charite.de.

Steffen Lukas (S)

Department of Radiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Marc Dewey (M)

Department of Radiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. dewey@charite.de.
Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany. dewey@charite.de.

Tobias Penzkofer (T)

Department of Radiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH